NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a letter from the FDA Office of Generic Drugs indicating only minor formatting comments on the proposed label for its preservative-free ketamine product, with a final label submission expected this month and potential approval of its Abbreviated New Drug Application anticipated in Summer 2026 pending final review. … Continue reading “QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application”

Frontieras North America held a groundbreaking ceremony in Point Pleasant, West Virginia, to mark the start of construction on its Mason County Plant, the company’s first commercial-scale facility utilizing its proprietary FASForm coal processing technology. Executives and local officials emphasized the project’s role in transforming coal into higher-value outputs, including ultra-low sulfur diesel, fertilizers and … Continue reading “QualityStocksNewsBreaks – Frontieras North America Marks Mason County Plant Groundbreaking With Ceremony in West Virginia”

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel T. Bradley will present and exhibit the Company’s DataValue(R), DataScore(R), Data Vault Bank(R) AI Agent and Information Data Exchange(R) technologies at XRP Tokyo 2026 on April 7, 2026, highlighting its AI-powered infrastructure for real-world asset tokenization as it targets Japan’s rapidly expanding, regulation-friendly market and broader APAC … Continue reading “QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Showcase RWA Tokenization Technologies at XRP Tokyo 2026”

Xeriant (OTCQB: XERI) announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for its patent covering a proprietary multilayered fire-resistant composite and manufacturing method, marking a key milestone for its DUREVER(TM) materials platform. The technology, featured in NEXBOARD(TM) composite wallboard, is advancing toward certification testing and is designed to deliver enhanced fire resistance, strength and sustainability across multiple … Continue reading “QualityStocksNewsBreaks – Xeriant, Inc. (OTCQB: XERI) Notice Of Allowance For Fire-Resistant Composite Patent “

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse … Continue reading “QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy “

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported a series of milestones advancing the scale and commercial potential of its Saskatchewan-based Natural Hydrogen portfolio, including successful drilling at the Bracken Well, completion of a high-resolution 3D seismic survey at the Lawson Discovery … Continue reading “QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Saskatchewan Natural Hydrogen Portfolio with New Discovery Milestones “

This article has been disseminated on behalf of NurExone Biologic and may include paid advertising.  NurExone Biologic (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) announced it received first place in the Healthcare category at the BOLD Awards VII Gala held March 27, 2026, in Barcelona, recognizing its leadership in exosome-based therapies for central nervous system injuries, and also provided a corporate update highlighting its selection by a panel of … Continue reading “QualityStocksNewsBreaks – NurExone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) Wins BOLD Awards VII Healthcare Honor, Engages IBN For Investor Outreach “

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced the release of its latest investor presentation, outlining strategy, technology development and commercial growth initiatives, including expanded global distribution efforts for its Overwatch solution. The platform delivers advanced targeting, geolocation … Continue reading “QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Releases Updated Investor Presentation Highlighting Growth Strategy”

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology innovator commercializing AI-powered voice analytics for real-time drug and alcohol impairment detection, is moving toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus … Continue reading “MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets South American Mining Sector as Voice-Based Drug and Alcohol Impairment Screening Platform Moves Toward Commercial Deployment”

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced defense systems. As demand accelerates and supply remains heavily concentrated … Continue reading “Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges”

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. As demand for organic food continues to grow across North America, attention is increasingly turning to the upstream inputs required to sustain that expansion. One of the most difficult inputs to scale has been phosphate fertilizer that complies … Continue reading “Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Targets Supply Gap in Fertilizer for Expanding Organic Food Market”

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for … Continue reading “Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication”

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Securing reliable supplies of specialized rare earth elements is becoming increasingly important as demand rises across defense, energy and advanced manufacturing sectors. With this in mind, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently announced that it is … Continue reading “Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Expands Strategy for Critical Magnet Materials Supply”

Beeline Holdings (NASDAQ: BLNE),  a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, reported strong revenue growth and improving loan economics in its recently reported fourth-quarter 2025 results, highlighting a strategy that combines digital mortgage origination with new fee-based real-estate finance products. The fintech lender posted net revenue of $2.5 million … Continue reading “Beeline Holdings Inc. (NASDAQ: BLNE) Reports 127% Revenue Growth and Key Milestones Achieved in Q4 2025, Detailing Strategic Priorities for 2026”

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing … Continue reading “LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes”

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. In today’s rapidly evolving battlefield, drones have become one of the most influential tools in modern warfare, reshaping how militaries gather intelligence, navigate contested environments, and execute operations. Yet as drone usage expands, so does the threat of GPS … Continue reading “GPS-Denied Navigation Isn’t Just a Problem for the Future, It’s Happening Right Now”